Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model

Cancer is the leading cause of death in several countries, and it is necessary to investigate new methods for effectively eradicating cancerous cells with fewer side effects. Immunotherapy, which has received considerable attention in recent years, is one of the most promising methods. However, one...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hossein Naderi, Mohammadmahdi Mehrabi, Mohammad Taghi Ahmadian
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Chemoimmunotherapy Adaptive control Fuzzy control Optimal control Cancer treatment Computer applications to medicine. Medical informatics R858-859.7
Acceso en línea:	https://doaj.org/article/eb620ce2455347b08b6897bcee16eeed
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:eb620ce2455347b08b6897bcee16eeed
record_format	dspace
spelling	oai:doaj.org-article:eb620ce2455347b08b6897bcee16eeed2021-11-16T04:10:51ZAdaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model2352-914810.1016/j.imu.2021.100782https://doaj.org/article/eb620ce2455347b08b6897bcee16eeed2021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352914821002537https://doaj.org/toc/2352-9148Cancer is the leading cause of death in several countries, and it is necessary to investigate new methods for effectively eradicating cancerous cells with fewer side effects. Immunotherapy, which has received considerable attention in recent years, is one of the most promising methods. However, one of the most significant challenges is integrating these novel methods and controlling the doses of various drugs. In this paper, optimal and adaptive fuzzy control is conducted on a recent comprehensive chemoimmunotherapy cancer model. Furthermore, chemotherapy and two methods of immunotherapy, including CD8+ T cells and cytokine IL-2 injection, are employed. The objectives are to determine the optimal combination of these treatments, identify the optimal drug injection routes during treatment, and control drug delivery to eradicate cancer cells when the dynamics of the cancer model are unknown. It is shown that performing immunotherapy methods alone, particularly cytokine IL-2 injection, are not very effective. However, when they are combined with chemotherapy, the most effective result is obtained. For instance, in the initial number of cancer cells of approximately 109, chemotherapy alone destroys the tumor in 49 days, while its combination with immunotherapy methods achieves this in 37 days. In addition, the designed fuzzy adaptive controller can destroy cancerous tumors when the model parameters are unknown. Fuzzy functions are established using training data, and they can efficiently estimate real model functions. A minimum of 10 days and a maximum of 40 days of experimentation during a 50-day treatment period are required to collect adequate training data for the cancer model's various state variables.Hossein NaderiMohammadmahdi MehrabiMohammad Taghi AhmadianElsevierarticleChemoimmunotherapyAdaptive controlFuzzy controlOptimal controlCancer treatmentComputer applications to medicine. Medical informaticsR858-859.7ENInformatics in Medicine Unlocked, Vol 27, Iss , Pp 100782- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Chemoimmunotherapy Adaptive control Fuzzy control Optimal control Cancer treatment Computer applications to medicine. Medical informatics R858-859.7
spellingShingle	Chemoimmunotherapy Adaptive control Fuzzy control Optimal control Cancer treatment Computer applications to medicine. Medical informatics R858-859.7 Hossein Naderi Mohammadmahdi Mehrabi Mohammad Taghi Ahmadian Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model
description	Cancer is the leading cause of death in several countries, and it is necessary to investigate new methods for effectively eradicating cancerous cells with fewer side effects. Immunotherapy, which has received considerable attention in recent years, is one of the most promising methods. However, one of the most significant challenges is integrating these novel methods and controlling the doses of various drugs. In this paper, optimal and adaptive fuzzy control is conducted on a recent comprehensive chemoimmunotherapy cancer model. Furthermore, chemotherapy and two methods of immunotherapy, including CD8+ T cells and cytokine IL-2 injection, are employed. The objectives are to determine the optimal combination of these treatments, identify the optimal drug injection routes during treatment, and control drug delivery to eradicate cancer cells when the dynamics of the cancer model are unknown. It is shown that performing immunotherapy methods alone, particularly cytokine IL-2 injection, are not very effective. However, when they are combined with chemotherapy, the most effective result is obtained. For instance, in the initial number of cancer cells of approximately 109, chemotherapy alone destroys the tumor in 49 days, while its combination with immunotherapy methods achieves this in 37 days. In addition, the designed fuzzy adaptive controller can destroy cancerous tumors when the model parameters are unknown. Fuzzy functions are established using training data, and they can efficiently estimate real model functions. A minimum of 10 days and a maximum of 40 days of experimentation during a 50-day treatment period are required to collect adequate training data for the cancer model's various state variables.
format	article
author	Hossein Naderi Mohammadmahdi Mehrabi Mohammad Taghi Ahmadian
author_facet	Hossein Naderi Mohammadmahdi Mehrabi Mohammad Taghi Ahmadian
author_sort	Hossein Naderi
title	Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model
title_short	Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model
title_full	Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model
title_fullStr	Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model
title_full_unstemmed	Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model
title_sort	adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/eb620ce2455347b08b6897bcee16eeed
work_keys_str_mv	AT hosseinnaderi adaptivefuzzycontrollerdesignofdrugdosageusingoptimaltrajectoriesinachemoimmunotherapycancertreatmentmodel AT mohammadmahdimehrabi adaptivefuzzycontrollerdesignofdrugdosageusingoptimaltrajectoriesinachemoimmunotherapycancertreatmentmodel AT mohammadtaghiahmadian adaptivefuzzycontrollerdesignofdrugdosageusingoptimaltrajectoriesinachemoimmunotherapycancertreatmentmodel
_version_	1718426760253538304

Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model

Ejemplares similares